Liquid biopsy in pancreatic cancer: the beginning of a new era

  title={Liquid biopsy in pancreatic cancer: the beginning of a new era},
  author={Dipesh Kumar Yadav and X. Bai and R. Yadav and Alina Singh and G. Li and T. Ma and Wei Chen and Tingbo Liang},
  pages={26900 - 26933}
  • Dipesh Kumar Yadav, X. Bai, +5 authors Tingbo Liang
  • Published 2018
  • Medicine
  • Oncotarget
  • With dismal survival rate pancreatic cancer remains one of the most aggressive and devastating malignancy. Predominantly, due to the absence of a dependable methodology for early identification and limited therapeutic options for advanced disease. However, it takes over 17 years to develop pancreatic cancer from initiation of mutation to metastatic cancer; therefore, if diagnosed early; it may increase overall survival dramatically, thus, providing a window of opportunity for early detection… CONTINUE READING
    24 Citations
    The Translational Status of Cancer Liquid Biopsies
    • 6
    • PDF
    ctDNA as a cancer biomarker: A broad overview.


    Circulating tumor DNA as a liquid biopsy for cancer.
    • 506
    • PDF
    Circulating and disseminated tumor cells in the management of breast cancer.
    • 92
    • PDF
    Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis
    • 27
    Liquid biopsy: monitoring cancer-genetics in the blood
    • 965
    • PDF
    Molecular therapeutics in pancreas cancer.
    • 16
    Integrating liquid biopsies into the management of cancer
    • 665
    • PDF
    Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
    • 102
    • Highly Influential
    • PDF
    Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
    • 34
    Imaging diagnosis of pancreatic cancer: a state-of-the-art review.
    • 196